Genedata Biologics allows us to digitalize our work, increasing quality and efficiency of our antibody discovery and protein production by integrating processes and connecting our global operations. Our partners and clients who also use the platform will see the benefit of easier information sharing.
Katherine Vousden, Ph.D. Head of Large Molecule Discovery
One of the reasons we chose Genedata was the platform’s process coverage. We required that the full diversity of Pfizer’s large-molecule processes and technologies be supported by one integrated system.
Sergio Rotstein, Ph.D. Director of Research Business Technology
We are excited to implement the Genedata Biopharma Platform as a central integrated data backbone to streamline the capture, integration, democratization, and analysis of increasingly complex and diverse data types.
Hisham Hamadeh, Ph.D. Vice President, Global Head of Data Sciences
We need to enhance our capacity to analyze large amounts of high-dimensional ‘omic data emerging from our rapidly growing number of translational and clinical research projects. We chose Genedata because it is the end-to-end enterprise software able to harmonize our dispersed data analysis pipelines.
Kimio Terao Department Manager of Clinical Pharmacology
We aimed to extend automation and further enhance the efficiency of our cell line, upstream and bioanalytical development operations, and quickly realized that Genedata addresses many of our requirements off-the-shelf, eliminating the need for expensive customization.
To optimally handle the complex data, we need a centralized genome knowledge management and analysis solution that addresses the interdisciplinary challenges in next-generation biotechnology innovations. Genedata was our obvious choice.
Harald Bradl, Ph.D. Director, Cell Culture and Process Sciences
Genedata provides comprehensive biologics data management functionality and the flexibility needed to support our proprietary antibody discovery processes and technology portfolio. And, it provides this functionality out-of-the-box, which saves valuable research time and money.
Markus Enzelberger, Ph.D. Senior Vice President and Head of Discovery, Alliances and Technologies
We especially appreciated the high level of expertise and support provided by Genedata, which enabled us to optimize every stage of our analytical processes—while incorporating industry best practices—and quickly generate high-quality results.
Juliet Padden Ph.D. Laboratory Head Analytical Development